$XTNT News

Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary

Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ...

Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript

BTIG Reiterates Buy on Xtant Medical Holdings, Maintains $1 Price Target

Xtant Medical Reports First Quarter 2026 Financial Results

Xtant Medical Hldgs Q1 2026 Earnings Call Transcript

Xtant Medical Raises FY2026 Sales Guidance from $95.000M-$99.000M to $101.000M-$105.000M vs $96.725M Est

Xtant Medical Hldgs Q1 EPS $(0.02), Inline, Sales $20.884M Beat $20.164M Estimate

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical Holdings Acquires Exclusive U.S. Distribution Rights To Dilon Technologies' HEMOBLAST Bellows

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Xtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary

Xtant Medical Q4 Earnings Call Highlights

BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript

Xtant Medical Hldgs Sees FY2026 Sales $95.000M-$99.000M vs $110.100M Est